An Immuno-therapy Study of Nivolumab in Combination With Experimental Medication BMS-986205 Compared to Standard of Care EXTREME Regimen in First-line Recurrent/Metastatic Squamous Cell Carcinoma of Head and Neck
Clinical trial NCT03386838 · WITHDRAWN
Trial details
- NCT number
- NCT03386838
- Sponsor
- Bristol-Myers Squibb
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-28
- Primary completion
- 2018-04-19
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.